Skip to main content
logo
Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
1.890
-0.200 (-9.57%)
At close: Aug 7, 2026, 4:00 PM EDT
1.820
-0.070 (-3.70%)
After-hours: Aug 7, 2026, 7:30 PM EDT

ZYBT Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
116.36116.36186.36211.65260.27214.07
Revenue Growth
-24.31%-37.56%-11.95%-18.68%21.58%-
Gross Profit
23.8723.8791.3117.51147.88125.39
Operating Income
-70.51-70.5116.4444.9965.8352.38
Net Income
-69.78-69.7811.3131.4646.7446.47
Earnings Per Share
-1.47-1.470.250.691.021.02
EPS Growth
---63.77%-32.35%0.25%-

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
51.8951.8920.0416.39.756.28
Total Debt
75.0875.0886.4389.8564.8830
Net Cash (Debt)
-23.19-23.19-66.4-73.55-55.13-23.72
Net Cash Growth
------
Net Cash Per Share
-0.49-0.49-1.45-1.61-1.21-0.52

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
13.3313.3341.0548.1817.3431.81
Capital Expenditures
-1.01-1.01-13.59-7.4-27.33-19.06
Free Cash Flow
12.3312.3327.4640.79-9.9912.75
Free Cash Flow Growth
3927.78%-55.12%-32.68%---

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
20.51%20.51%48.99%55.52%56.82%58.58%
Operating Margin
-60.59%-60.59%8.82%21.25%25.29%24.47%
Pretax Margin
-61.77%-61.77%7.72%20.68%24.56%24.79%
Profit Margin
-71.30%-71.30%7.23%17.72%21.42%21.71%
FCF Margin
10.59%10.59%14.73%19.27%-3.84%5.95%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
48.3930.94----
PS Ratio
5.313.28----